EyePoint (EYPT) Current Leases (2019)

EyePoint (EYPT) reported Current Leases of $481000.0 for Q4 2019, up 4.34% sequentially from $461000.0 in Q3 2019.

EyePoint (EYPT) Current Leases (2019) Analysis & Trends

EyePoint (EYPT) has 1 years of Current Leases data on file, last reported at $481000.0 in Q4 2019.

For the quarter ending Q4 2019, Current Leases changed N/A year-over-year to $481000.0; the trailing twelve-month figure through Dec 2019 stood at $481000.0 (changed N/A YoY), and the FY2019 full-year result was $481000.0, changed N/A from the prior year.
Current Leases rose to $481000.0 in Q4 2019, from $461000.0 in the prior quarter.
In the past five years, Current Leases ranged from a high of $481000.0 in Q4 2019 to a low of $417000.0 in Q1 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	531,233.95
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	20.58 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	872,589.03
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	720.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	11.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	16.61 Mn
10	EyePoint	358.61 Mn	136.07 Mn	168,000.00	-

Download Data